BRIGHT MINDS BIOSCIENCES INC. (DRUG) Return on equity
BRIGHT MINDS BIOSCIENCES INC. (DRUG) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DRUGSource: SEC XBRL filings · For reference only · Not investment advice
More DRUG financial trends
DRUG RevenueDRUG Net incomeDRUG Net marginDRUG Gross profitDRUG Gross marginDRUG Operating incomeDRUG Operating marginDRUG Operating cash flowDRUG Free cash flowDRUG Capital expendituresDRUG Stock buybacksDRUG Dividends paidDRUG Total assetsDRUG Total liabilitiesDRUG Shareholders’ equityDRUG overview →